Valvular heart disease is common and its prevalence is rapidly increasing worldwide.
Effective medical therapies are insufficient and treatment was historically limited to the …

Transcatheter aortic valve replacement is now indicated across all risk categories of patients
with symptomatic severe aortic stenosis and has been proposed as first line option for the …

Since the first-in-human procedure in 2002, transcatheter aortic valve implantation (TAVI)
has become a well-established therapeutic option for severe aortic stenosis, and is offered …

Background Transcatheter aortic valve implantation in an existing transcatheter valve (redo-
TAVI) pins the index valve leaflets in the open position (neoskirt), which can cause coronary …

Transcatheter aortic valve replacement (TAVR) indications recently extended to lower
surgical risk patients with longer life expectancy. Commissural alignment (CA) is one of the …

Background Coronary obstruction and access are concerns in patients undergoing redo
transcatheter aortic valve implantation (TAVI). Aims We sought to assess the neoskirt height …

Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) is emerging as an
effective treatment for patients with symptomatically failing bioprosthetic valves and a high …

BACKGROUND: Coronary accessibility following redo–transcatheter aortic valve
replacement (redo-TAVR) is increasingly important, particularly in younger low-risk patients …

Abstract Purpose of Review As TAVR is increasingly performed on younger patients with a
longer life expectancy, the number of redo-TAVR procedures is likely to increase in the …

Coronary obstruction (CO) is a rare but critical complication of transcatheter aortic valve
implantation. It is associated with significant morbidity and mortality. This comprehensive …